+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

North America Digital Pathology Market By Product, By End Use, By Application, By Country, Industry Analysis and Forecast, 2020 - 2026

  • PDF Icon

    Report

  • 90 Pages
  • February 2021
  • Region: North America
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5305650
The North America Digital Pathology Market is expected to witness market growth of 5.5% CAGR during the forecast period (2020-2026).

The market growth will be fuelled by the rising focus on enhancing effective workflow & demand for quick diagnostic instruments for chronic diseases like cancer. The rates of chronic diseases are consistently increasing, which will result in a spike in clinical urgency to accept digital pathology with an aim to minimize huge cost of conventional diagnostics & to enhance existing poor patient diagnostic imaging measures.

An image-based technology in the pathology domain that includes capturing, interpreting, analyzing, and operating digital information from a glass slide is termed as Digital Pathology. In this process, the digital slide image file is created with the help of aspects such as high-resolution viewing, interpretation, and image analysis of digital pathology slides can be obtained.

The growth of the market is expected to be fuelled as digital pathology shows applications for various disease diagnoses including the cancer. Additionally, the market is expected to witness lucrative growth opportunities due to the increasing installation of digital pathology as a cost-effective diagnostic method & these systems offer a better imaging features of patient diagnostic.

Based on Product, the market is segmented into Device, Software and Storage System. Based on End Use, the market is segmented into Hospitals, Diagnostic Labs, Biotech & pharma companies and Academic & research institutes. Based on Application, the market is segmented into Drug Discovery & Development, Disease Diagnosis and Academic research. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The US market dominated the North America Software Market by Country in 2019, thereby, achieving a market value of $90.4 Million by 2026. The Canada market is experiencing a CAGR of 7.2% during (2020 - 2026). Additionally, The Mexico market is expected to witness a CAGR of 7% during (2020 - 2026).

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Danaher Corporation (Leica Biosystems), Koninklijke Philips N.V., Olympus Corporation, F. Hoffmann-La Roche Ltd., ContextVision AB, Hamamatsu Photonics K.K., Mikroscan Technologies, Inc., Inspirata, Inc., Visiopharm A/S, and 3DHISTECH Ltd.

Scope of the Study

Market Segments covered in the Report:

By Product
  • Device
  • Software
  • Storage System

By End Use
  • Hospitals
  • Diagnostic Labs
  • Biotech & pharma companies
  • Academic & research institutes

By Application
  • Drug Discovery & Development
  • Disease Diagnosis
  • Academic research

By Country
  • US
  • Canada
  • Mexico
  • Rest of North America

Companies Profiled
  • Danaher Corporation (Leica Biosystems)
  • Koninklijke Philips N.V.
  • Olympus Corporation
  • F. Hoffmann-La Roche Ltd.
  • ContextVision AB
  • Hamamatsu Photonics K.K.
  • Mikroscan Technologies, Inc.
  • Inspirata, Inc.
  • Visiopharm A/S
  • 3DHISTECH Ltd.

Unique Offerings from the Publisher
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Digital Pathology Market, by Product
1.4.2 North America Digital Pathology Market, by End Use
1.4.3 North America Digital Pathology Market, by Application
1.4.4 North America Digital Pathology Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Approvals
3.2.4 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2017, Oct - 2021, Feb) Leading Players
Chapter 4. North America Digital Pathology Market by Product
4.1 North America Device Market by Country
4.2 North America Software Market by Country
4.3 North America Storage System Market by Country
Chapter 5. North America Digital Pathology Market by End-use
5.1 North America Hospitals Market by Country
5.2 North America Diagnostic Labs Market by Country
5.3 North America Biotech & pharma companies Market by Country
5.4 North America Academic & research institutes Market by Country
Chapter 6. North America Digital Pathology Market by Application
6.1 North America Drug Discovery & Development Market by Country
6.2 North America Disease Diagnosis Market by Country
6.3 North America Academic research Market by Country
Chapter 7. North America Digital Pathology Market by Country
7.1 US Digital Pathology Market
7.1.1 US Digital Pathology Market by Product
7.1.2 US Digital Pathology Market by End-use
7.1.3 US Digital Pathology Market by Application
7.2 Canada Digital Pathology Market
7.2.1 Canada Digital Pathology Market by Product
7.2.2 Canada Digital Pathology Market by End-use
7.2.3 Canada Digital Pathology Market by Application
7.3 Mexico Digital Pathology Market
7.3.1 Mexico Digital Pathology Market by Product
7.3.2 Mexico Digital Pathology Market by End-use
7.3.3 Mexico Digital Pathology Market by Application
7.4 Rest of North America Digital Pathology Market
7.4.1 Rest of North America Digital Pathology Market by Product
7.4.2 Rest of North America Digital Pathology Market by End-use
7.4.3 Rest of North America Digital Pathology Market by Application
Chapter 8. Company Profiles
8.1 Danaher Corporation (Leica Biosystems)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental &Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Product Launches and Product Expansions:
8.2 Koninklijke Philips N.V.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.3 Olympus Corporation
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.4 F. Hoffmann-La Roche Ltd.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Product Launches and Product Expansions:
8.5 ContextVision AB
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Recent strategies and developments:
8.5.4.1 Approvals:
8.6 Hamamatsu Photonics K.K.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.7 Mikroscan Technologies, Inc.
8.7.1 Company Overview
8.7.2 Recent strategies and developments:
8.7.2.1 Partnerships, Collaborations, and Agreements:
8.8 Inspirata, Inc.
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Partnerships, Collaborations, and Agreements:
8.8.2.2 Acquisition and Mergers:
8.9 Visiopharm A/S
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Partnerships, Collaborations, and Agreements:
8.9.2.2 Product Launches and Product Expansions:
8.9.2.3 Acquisition and Mergers:
8.10. 3DHISTECH Ltd.
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Product Launches and Product Expansions:

Companies Mentioned

  • Danaher Corporation (Leica Biosystems)
  • Koninklijke Philips N.V.
  • Olympus Corporation
  • F. Hoffmann-La Roche Ltd.
  • ContextVision AB
  • Hamamatsu Photonics K.K.
  • Mikroscan Technologies, Inc.
  • Inspirata, Inc.
  • Visiopharm A/S
  • 3DHISTECH Ltd.

Methodology

Loading
LOADING...